DE1436140U - - Google Patents

Info

Publication number
DE1436140U
DE1436140U DENDAT1436140D DE1436140DU DE1436140U DE 1436140 U DE1436140 U DE 1436140U DE NDAT1436140 D DENDAT1436140 D DE NDAT1436140D DE 1436140D U DE1436140D U DE 1436140DU DE 1436140 U DE1436140 U DE 1436140U
Authority
DE
Germany
Prior art keywords
ird
velrlngdrt
ufdßsum
uchsun
tteprfiche
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DENDAT1436140D
Other languages
German (de)
English (en)
Publication of DE1436140U publication Critical patent/DE1436140U/de
Active legal-status Critical Current

Links

Landscapes

  • Hybrid Cells (AREA)
  • Primary Cells (AREA)
DENDAT1436140D Active DE1436140U (cg-RX-API-DMAC7.html)

Publications (1)

Publication Number Publication Date
DE1436140U true DE1436140U (cg-RX-API-DMAC7.html)

Family

ID=744865

Family Applications (1)

Application Number Title Priority Date Filing Date
DENDAT1436140D Active DE1436140U (cg-RX-API-DMAC7.html)

Country Status (1)

Country Link
DE (1) DE1436140U (cg-RX-API-DMAC7.html)

Similar Documents

Publication Publication Date Title
EP0702560B1 (en) Immunologic enhancement with intermittent interleukin-2 therapy
Laurence et al. Acquired immunodeficiency without evidence of infection with human immunodeficiency virus types 1 and 2
Lane et al. Anti-retroviral effects of interferon-α in AIDS-associated Kaposi's sarcoma
Redding et al. Resistance of Candida albicans to fluconazole during treatment of oropharyngeal candidiasis in a patient with AIDS: documentation by in vitro susceptibility testing and DNA subtype analysis
Krown et al. Efficacy of low-dose interferon with antiretroviral therapy in Kaposi's sarcoma: a randomized phase II AIDS clinical trials group study
Israël-Biet et al. Tumor necrosis factor production in HIV-seropositive subjects. Relationship with lung opportunistic infections and HIV expression in alveolar macrophages
DE1436140U (cg-RX-API-DMAC7.html)
CN1072654C (zh) 苯甲酰胺衍生物,含所述衍生物的组合物及它们的用途
US5696079A (en) Immunologic enhancement with intermittent interleukin-2 therapy
Sperber et al. Anti-HIV-1 activity of recombinant and hybrid species of interferon-α
CN1187054C (zh) 含中药环维黄杨星d的渗透泵控释制剂及其制备方法
RU2004129000A (ru) Способ нанесения покрытия
WO2019107986A1 (ko) 피마살탄을 포함하는 약학적 조성물
US20030180254A1 (en) Immunologic enhancement with intermittent interleukin-2 therapy
DE1409138U (cg-RX-API-DMAC7.html)
AP132A (en) Improved formulation of low-dose interferon alpha.
DE1426030U (cg-RX-API-DMAC7.html)
RU2004130610A (ru) Субстанция для профилактики и лечения вич-инфекции и микробицидный гель на ее основе (его варианты)
DE1308148U (cg-RX-API-DMAC7.html)
CN1163271C (zh) 一种合成肽流感疫苗的制备方法
CN1502339A (zh) 稀土杂多酸盐（蓝）类抗艾滋病药物及其制备方法
Li et al. A conserved structural motif shared by EIAV gp90 and HIV gp120
WO2025012105A3 (en) Muteins of human interleukin 12
Yamauchi et al. Dynamic Fatigue Behavior of Ceramics at Elevated Temperatures
Bettoli et al. Cutaneous cryptococcosis in AIDS: successful treatment with itraconazole: Haut‐Cryptococcose bei AIDS: Erfolgreiche Behandlung mit Itraconazol